Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
RATIONALE: Drugs used in chemotherapy, such as capecitabine, irinotecan, and oxaliplatin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase I trial is studying the side effects and best dose of capecitabine when given together with irinotecan and oxaliplatin in treating patients with metastatic cancer.
Epistemonikos ID: 8f71fc6f615e914dabfd0bf523b31a42424fa579
First added on: May 04, 2024